Results 191 to 200 of about 658,368 (320)

Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin‐resistant tuberculosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Moxifloxacin is a priority drug for treating rifampicin‐resistant tuberculosis (RR‐TB). We assessed the pharmacokinetics of a child‐friendly, dispersible 100 mg tablet moxifloxacin formulation (dispersed in water) compared to the standard 400 mg non‐dispersible formulation (crushed and suspended in water) in children and evaluated current dosing ...
Megan Palmer, Yuanxi Zou, Anneke C. Hesseling, Louvina van der Laan, Ingrid Courtney, Aarti A. Kinikar, Naresh Sonkawade, Mandar Paradkar, Vandana Kulkarni, Dessa Jean O. Casalme, Melchor V. G. Frias, Heather Draper, Lubbe Wiesner, Mats O. Karlsson, Paolo Denti, Elin M. Svensson, Anthony J. Garcia‐Prats   +16 more
wiley   +1 more source

Determination of Anti-cardiolipin and Other Antibodies in HIV-1-Infected Patients

, 1990
C. Bernard, B. Exquis, G. Reber, P. De Moerloose   +3 more
openalex   +1 more source

Differences in HIV-1 reservoir size, landscape characteristics, and decay dynamics in acute and chronic treated HIV-1 Clade C infection. [PDF]

Elife
Reddy K, Lee GQ, Reddy N, Chikowore TJB, Baisley K, Dong KL, Walker BD, Yu XG, Lichterfeld M, Ndung'u T.   +9 more
europepmc   +1 more source

Adverse events associated with monoclonal antibodies used for treatment of COVID‐19: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims This review aimed to synthesise the evidence related to the incidence of serious and non‐serious adverse events with the use of monoclonal antibodies (mAbs) among COVID‐19 patients. Methods Databases were searched from January 2020 to September 2023 for randomized clinical trials (RCTs) that used mAbs for the treatment of COVID‐19 regardless of ...
Htet Htet, Han You Kyung, Ismail Abdul Sattar Burud, Heethal Jaiprakash, Thiruselvi Subramaniam, Igor Iezhitsa, Renu Agarwal   +6 more
wiley   +1 more source

INHIBITION OF HIV-1 RNA PRODUCTION BY THE DIPHTHERIA TOXIN-RELATED IL-2 FUSION PROTEINS DAB486IL-2 AND DAB389IL-2

, 1992
Zhang Lin, Cory A. Waters, Jean Nichols, Clyde S. Crumpacker   +3 more
openalex   +1 more source

Trans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase C. [PDF]

, 1990
Aya Jakobovits, A S Rosenthal, Daniel J. Capon   +2 more
openalex   +1 more source

Pretreatment HIV-1 Drug Resistance Among Newly Diagnosed People in Eastern Ethiopia. [PDF]

Health Sci Rep
Gemechu A, Mihret A, Mengesha M, Alemayehu DH, Kidane E, Aseffa A, Howe R, Seyoum B, Mulu A.   +8 more
europepmc   +1 more source

General practitioner consultation for postmenopausal bleeding after COVID‐19 vaccination—a self‐controlled cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aims The incidence of postmenopausal bleeding (PMB) has been increasing over the past years. Little is known about the risk of PMB after COVID‐19 vaccination. Our study aimed to investigate this based on routine general practitioner (GP) healthcare data from the Netherlands.
Rana Jajou, Eugène P. van Puijenbroek, Renee Veldkamp, Jetty A. Overbeek, Florence P. A. M. van Hunsel, Agnes C. Kant   +5 more
wiley   +1 more source

Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Genital Ulcer Exudate of HIV-1-Infected Men by Culture and Gene Amplification [PDF]

, 1990
FA Plummer, Mark A. Wainberg, Pierre Plourde, Peter Jessamine, L J D'Costa, Isaac A Wamola, Allan Ronald   +6 more
openalex   +1 more source

The changing molecular epidemiology of HIV-1 in Liangshan prefecture, China, in 2021-2023. [PDF]

Front Microbiol
Pei R, Su L, Jike C, Yu G, Wang J, Xiao L, Wang Y, Shen M, Zhou C, Liao J, Zhang Y, Zheng Y, Hemelaar J.   +12 more
europepmc   +1 more source